Your browser doesn't support javascript.
loading
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis.
Verboven, Elisabeth; Moya, Iván M; Sansores-Garcia, Leticia; Xie, Jun; Hillen, Hanne; Kowalczyk, Weronika; Vella, Gerlanda; Verhulst, Stefaan; Castaldo, Stéphanie A; Algueró-Nadal, Ana; Romanelli, Lucia; Mercader-Celma, Cristina; Souza, Natália A; Soheily, Soheil; Van Huffel, Leen; Van Brussel, Thomas; Lambrechts, Diether; Roskams, Tania; Lemaigre, Frédéric P; Bergers, Gabrielle; van Grunsven, Leo A; Halder, Georg.
Afiliação
  • Verboven E; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Moya IM; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium; Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Americas, Quito, Ecuador.
  • Sansores-Garcia L; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Xie J; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Hillen H; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Kowalczyk W; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Vella G; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Verhulst S; Liver Cell Biology Research Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussel, Belgium.
  • Castaldo SA; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Algueró-Nadal A; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Romanelli L; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Mercader-Celma C; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Souza NA; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Soheily S; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Van Huffel L; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Van Brussel T; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Lambrechts D; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Roskams T; Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
  • Lemaigre FP; Liver and Pancreas Development Unit, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
  • Bergers G; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • van Grunsven LA; Liver Cell Biology Research Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussel, Belgium.
  • Halder G; Vlaams Instituut voor Biotechnologie-Katholieke Universiteit Leuven, Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium. Electronic address: georg.halder@vib.be.
Gastroenterology ; 160(3): 847-862, 2021 02.
Article em En | MEDLINE | ID: mdl-33127392
BACKGROUND AND AIMS: The Hippo pathway and its downstream effectors YAP and TAZ (YAP/TAZ) are heralded as important regulators of organ growth and regeneration. However, different studies provided contradictory conclusions about their role during regeneration of different organs, ranging from promoting proliferation to inhibiting it. Here we resolve the function of YAP/TAZ during regeneration of the liver, where Hippo's role in growth control has been studied most intensely. METHODS: We evaluated liver regeneration after carbon tetrachloride toxic liver injury in mice with conditional deletion of Yap/Taz in hepatocytes and/or biliary epithelial cells, and measured the behavior of different cell types during regeneration by histology, RNA sequencing, and flow cytometry. RESULTS: We found that YAP/TAZ were activated in hepatocytes in response to carbon tetrachloride toxic injury. However, their targeted deletion in adult hepatocytes did not noticeably impair liver regeneration. In contrast, Yap/Taz deletion in adult bile ducts caused severe defects and delay in liver regeneration. Mechanistically, we showed that Yap/Taz mutant bile ducts degenerated, causing cholestasis, which stalled the recruitment of phagocytic macrophages and the removal of cellular corpses from injury sites. Elevated bile acids activated pregnane X receptor, which was sufficient to recapitulate the phenotype observed in mutant mice. CONCLUSIONS: Our data show that YAP/TAZ are practically dispensable in hepatocytes for liver development and regeneration. Rather, YAP/TAZ play an indirect role in liver regeneration by preserving bile duct integrity and securing immune cell recruitment and function.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colestase / Proteínas Adaptadoras de Transdução de Sinal / Doença Hepática Induzida por Substâncias e Drogas / Regeneração Hepática Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colestase / Proteínas Adaptadoras de Transdução de Sinal / Doença Hepática Induzida por Substâncias e Drogas / Regeneração Hepática Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica